View Post

T2DM in Middle Age Ups Mortality Risk in COVID-19 Infection

In COVID-19, Latest News
by HealthdayFebruary 19, 2021

Excess COVID-19 death risk from type 2 diabetes decreases with increasing age

View Post

Euglycemic DKA ID’d in T2DM Patients With COVID-19

In COVID-19, Latest News
by HealthdayJanuary 5, 2021

Five cases of euDKA identified in patients with type 2 diabetes using SGLT2 inhibitors who developed SARS-CoV-2 infection

View Post

Risk of Severe COVID-19 Up Among Those With Diabetes

In COVID-19, Latest News
by HealthdayDecember 14, 2020

Risk for severe COVID-19 similar among those with type 1 and type 2 diabetes

View Post

AHA: Sotagliflozin Beneficial for T2DM With Heart Failure

In COVID-19, Latest News
by HealthdayNovember 25, 2020

Second study shows benefits among patients with type 2 diabetes and chronic kidney disease, risks for CVD

View Post

Sitagliptin May Cut Mortality in T2DM Patients With COVID-19

In COVID-19, Critical Care, Emergency Medicine, Family Practice, Geriatrics, HealthDay News, Internal Medicine, Latest News, Pharmacy
by HealthdayOctober 14, 2020

Sitagliptin at time of hospitalization linked to reduced mortality, improved clinical outcomes